Hypertension, or high blood pressure, is a common, serious, and often symptomless condition that can remain dangerously unrecognized for years. Diet modification and pharmacologic interventions to lower blood pressure can affect existing cardiometabolic concerns such as kidney disease and diabetes, so clinicians must be aware of the guidelines in these populations before implementing care.
The latest industry news, CMHC Pulse Blogs and Cardiometabolic Chronicle articles related to hypertension.
Endocrine-Metabolic Consequences of Chronic Maternal Hypertension
Maternal hypertension and hypertensive disorders during pregnancy have been proven to significantly increase the risk of perinatal health complications in both mothers and their offspring.
Racial Inequities in Hypertension Treatment Intensification
Despite experiencing an increased risk for hypertension, Black patients often constitute a small proportion of clinical trial participants leading to a lack of data supporting
Black History Month: Hypertension in African American Adults
As results of the REGARDS study indicate, African American patients are more likely to be aware of having hypertension, more likely to be undergoing treatment,
Optimal Blood Pressure Guidelines for CAD Prevention in T1D Patients
Hypertension is a major risk factor for cardiometabolic disease and is common among the American population with nearly 1 in 3 adults suffering from high
New Guidelines for High Blood Pressure
According to a joint statement issued Monday by the American Heart Association and the American College of Cardiology, nearly half of all adult Americans will
Increases in Pediatric Hypertension
More children and teens are likely to be categorized as having abnormal blood pressure during their annual wellness visits, based on new recommendations released this week by
Baxdrostat for Treatment-Resistant Hypertension
Investigators reported that baxdrostat – at several dose levels – reduced plasma aldosterone levels but not cortisol levels in results from the recent BrigHTN study
Expert Highlights and Perspectives
A cache of recorded faculty presentations addressing the diagnosis, clinical management, treatment, and emerging strategies related to hypertension.
Recap of Important Updates in Cardiometabolic Medicine in 2022
CMHC co-chairs Drs. Robert Eckel, George Bakris, Christie Ballantyne and CMHC Senior Planning Committee members Drs Deepak Bhatt and Keith Ferdinand recap important highlights of key trials and developments in cardiometabolic medicine in 2022, including obesity, hypertension, chronic kidney disease, heart failure, dyslipidemia, atherothrombosis and more. (Recorded October 20, 2022)
A collection of resources related to hypertension for both patients and provider education and connection.
ASO = antisense oligonucleotide; RNAi = RNA interference
Available courses, certification information, and the latest educational opportunities for practitioners interested in beginning or continuing their careers in a cardiometabolic subspecialty with emphasis on hypertension.